Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-DM1 in HER2-positive mCRC after Trastuzumab and Lapatinib (HERACLES RESCUE)
NCT03418558Phase 2Unknown
- Sponsor
- Fondazione del Piemonte per l'Oncologia
- Start
- Jul 2015
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab emtansine in colorectal cancer (metastatic) (mCRC), sponsored by Fondazione del Piemonte per l'Oncologia. Status: unknown.
02
Drugs
trastuzumab emtansine
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT03418558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418558.